Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Lung Neoplasms 5 Glioblastoma 4 Urinary Bladder Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Brain Neoplasms 3 Pancreatic Neoplasms 2 Lung Diseases 2 Glioma 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Tuberculosis, Pulmonary 1 Thyroid Nodule 1 Stomach Neoplasms 1 Solitary Pulmonary Nodule 1 Pulmonary Fibrosis 1 Pulmonary Embolism 1 Pulmonary Disease, Chronic Obstructive 1 Pulmonary Arterial Hypertension 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pancreatic Cyst 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Pulmonary Nodules 1 Mouth Neoplasms 1 Mesothelioma 1 Medication Adherence 1

Interventions

Therapeutics 31 Psychiatric Rehabilitation 27 Surveys and Questionnaires 15 Cognitive Behavioral Therapy 12 Early Intervention, Educational 10 Psilocybin 9 Ketamine 9 Methods 8 Saline Solution 7 Yoga 6 Mindfulness-Based Cognitive Therapy 6 Interviews as Topic 6 Esketamine 6 Counseling 6 Psychosocial Intervention 5 Mindfulness 5 Methylphenidate 5 Escitalopram 5 Educational Status 5 Behavior Therapy 5 Acupuncture Therapy 5 Palliative Care 4 Exercise Therapy 4 Exercise 4 Control Groups 4 Caregivers 4 Standard of Care 3 Psychotherapy 3 Niacin 3 Mindfulness-Based Stress Reduction 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Depression × Drug Delivery Systems × Clear all

NCT01701284 2023-11-18

rTMSinCP

Northwestern University

Phase NA Completed

Anxiety Disorders, Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡